Murine Cytomegalovirus Immediate-Early 1 Gene Expression Correlates with Increased GVHD after Allogeneic Hematopoietic Cell Transplantation in Recipients Reactivating from Latent Infection
Open Access
- 15 April 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4), e61841
- https://doi.org/10.1371/journal.pone.0061841
Abstract
The success of allogeneic (allo) hematopoietic cell transplantation (HCT) is limited by its treatment related complications, mostly graft versus host disease (GVHD) and fungal and viral infections. CMV reactivation after HCT has been associated with increased morbidity and mortality, and a causal relation between GVHD, immunosuppressive therapy and vice versa has been postulated. Using a low GVHD severity murine HCT model, we assessed the role of MCMV reactivation and GVHD development. BALB/c mice were infected with either murine CMV (MCMV) or mock and monitored for 25 weeks to establish latency, followed by sublethal irradiation conditioning and infusion of bone marrow plus splenocytes from either syngeneic (syn) BALB/c or allo B10.D2 donors. Engraftment of allo donor cells was confirmed by PCR for D 2Mit265 gene product size. Day+100 mortality and overall GVHD severity in allo MCMV pre-infected recipients was higher than in allo mock controls. Pathologic changes of lung and liver GVHD in immediate-early gene 1 (IE1) positive recipients were significantly increased compared to mock controls, and were only slightly increased in IE1 negative. No significant gut injury was seen in any group. Aggravated lung injury in IE1 positive recipients correlated with higher BAL cell counts both for total cells and for CD4+ T cells when compared with mock controls, and also with protein expression of lung IFN-gamma and liver TNF. No evidence for CMV specific morphologic changes was seen on histopathology in any organ of IE1 positive recipients, suggesting that CMV reactivation is related to increased GVHD severity but does not require active CMV disease, strengthening the concept of a reciprocal relationship between CMV and GVHD.Keywords
This publication has 47 references indexed in Scilit:
- Human cytomegalovirus immunity and immune evasionVirus Research, 2011
- The Impact of Early Viral Infections and Graft‐Versus‐Host Disease on Immune Reconstitution Following Paediatric Stem Cell TransplantationScandinavian Journal of Immunology, 2011
- Role of the gut-associated and secondary lymphoid tissue in the induction of chronic colitisInflammatory Bowel Diseases, 2011
- Increased morbidity and mortality in murine cytomegalovirus-infected mice following allogeneic bone marrow transplant is associated with reduced surface decay accelerating factor expressionClinical and Experimental Immunology, 2010
- Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associatedBone Marrow Transplantation, 2010
- A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMTBone Marrow Transplantation, 2009
- Liver Sinusoidal Endothelial Cells Are a Site of Murine Cytomegalovirus Latency and ReactivationJournal of Virology, 2009
- Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latencyMedical Microbiology and Immunology, 2007
- Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantationTransplant Immunology, 2004
- The murine cytomegalovirus immediate-early 1 protein stimulates NF-κ B activity by transactivating the NF-κ B p105/p50 promoterVirus Research, 1996